Literature DB >> 26248743

The influence of low molecular weight heparin medication on plasma DNA in pregnant women.

Sebastian Grömminger1, Sanli Erkan2, Ulrike Schöck1, Kerstin Stangier3, Joachim Bonnet1, Rüdiger Schloo4, Angela Schubert5, Eva-Christina Prott6, Ute Knoll7, Markus Stumm7, Christof von Kalle8, Wera Hofmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26248743     DOI： 10.1002/pd.4668

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN： 0197-3851            Impact factor:   3.050


× No keyword cloud information.
  13 in total

Review 1.  Noninvasive prenatal testing for aneuploidy using cell-free DNA - New implications for maternal health.

Authors:  Lisa Hui
Journal:  Obstet Med       Date:  2016-06-07

2.  Repeated failed non-invasive prenatal testing in a woman with immune thrombocytopenia and antiphospholipid syndrome: lessons learnt.

Authors:  C Y Y Hui; W C Tan; E L Tan; L K Tan
Journal:  BMJ Case Rep       Date:  2016-12-05

Review 3.  Screening for fetal chromosomal and subchromosomal disorders.

Authors:  Sarah Harris; Dallas Reed; Neeta L Vora
Journal:  Semin Fetal Neonatal Med       Date:  2017-11-08       Impact factor: 3.926

4.  The impact of maternal autoimmune disease on cell-free DNA test characteristics.

Authors:  Hayley J MacKinnon; Teodora R Kolarova; Ronit Katz; Jaclynne M Hedge; Elena Vinopal; Christina M Lockwood; Raj Shree; Shani Delaney
Journal:  Am J Obstet Gynecol MFM       Date:  2021-08-18

5.  Association of fetal fraction with hypertensive disorders of pregnancy incidence and disease severity.

Authors:  Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Christina M Lockwood; Suchitra Chandrasekaran
Journal:  Am J Obstet Gynecol MFM       Date:  2022-05-27

6.  The Effect of Elevated Alanine Transaminase on Non-invasive Prenatal Screening Failures.

Authors:  Ping Chen; Longwei Qiao; Sheng Zhang; Jieyu Jin; Jun Cao; Yuqiong Zhang; Haoyu Tang; Zheng Yu; Jingye Shi; JingPing Yin; Yuting Liang; Xiao Wu
Journal:  Front Med (Lausanne)       Date:  2022-06-15

7.  Autoimmune disorders but not heparin are associated with cell-free fetal DNA test failure.

Authors:  Yohann Dabi; Sarah Guterman; Jacques C Jani; Alexandra Letourneau; Adèle Demain; Pascale Kleinfinger; Laurence Lohmann; Jean-Marc Costa; Alexandra Benachi
Journal:  J Transl Med       Date:  2018-12-03       Impact factor: 5.531

8.  Low fetal fraction in obese women at first trimester cell-free DNA based prenatal screening is not accompanied by differences in total cell-free DNA.

Authors:  Raj Shree; Teodora R Kolarova; Hayley J MacKinnon; Jaclynne M Hedge; Elena Vinopal; Kimberly K Ma; Christina M Lockwood; Suchitra Chandrasekaran
Journal:  Prenat Diagn       Date:  2021-08-14       Impact factor: 3.242

9.  Prenatal cell-free DNA screening for fetal aneuploidy in pregnant women at average or high risk: Results from a large US clinical laboratory.

Authors:  Carrie Guy; Farnoosh Haji-Sheikhi; Charles M Rowland; Ben Anderson; Renius Owen; Felicitas L Lacbawan; Damian P Alagia
Journal:  Mol Genet Genomic Med       Date:  2019-01-31       Impact factor: 2.183

10.  Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood.

Authors:  Joost C de Vries; Arjan D Barendrecht; Chantal C Clark; Rolf T Urbanus; Peter Boross; Steven de Maat; Coen Maas
Journal:  Sci Rep       Date:  2019-12-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.